Analyst Ratings for Clementia Pharmaceuticals Inc. (CMTA) [Neutrals]
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/4/2019 | Baird | Madhu Kumar | Downgrade | Neutral (Outperform) |
27.00 (N/A) |
25.83 (26.35) |
2.01% | Details |
| 2/26/2019 | Leerink Partners | Joseph Schwartz | Downgrade | Market Perform (Outperform) |
26.00 (28.00) |
14.94 (26.35) |
76.37% | Details |
 |
||||||||
